ArticlePediatric rheumatology online journal2023

Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.